Given
the very high survival rate for patients with Hodgkin lymphoma, many research studies now focus on learning how to eliminate potential late effects (e.g., secondary cancers) while maintaining excellent outcomes.
Not exact matches
The researchers found that at five years,
very few patients who received chemotherapy experienced disease relapses, showing
high rates of distant metastases - free
survival, disease - free
survival and overall
survival, which confirms that they derived benefit from chemotherapy.
In an increasingly competitive sphere where there is
very little discrepancy between purported student satisfaction
ratings, «gaming» the system is about more than overbearing pressure from on
high, it is a
survival tactic.